Review Article
Year: 2017 | Month: March | Volume: 2 | Issue: 1 | Pages: 26-30
Gingival Overgrowth: An Enigma to Periodontists!
Dr. Rosiline James
Post Graduate Student, Rural Dental College, Pravara Institute of Medical Sciences, Loni, India
ABSTRACT
Gingival overgrowth which is an abnormal growth of the periodontal tissue is mainly associated with dental plaque-related inflammation and drug therapy. Its true incidence in the general population is unknown. Gingival enlargement produces aesthetic changes, pain, gingival bleeding and periodontal disorders. The three classes of drugs namely, anti epileptic, immune-suppressive, produce important changes in fibroblast function, which induce an increase in the extracellular matrix of the gingival connective tissue. In the majority of those patients for whom dosage reduction, or drug discontinuation or substitution is not possible, and for whom prophylactic measures have failed, surgical excision of gingival tissue remains the only treatment of choice. Brunet et al. [1]
Key words: Gingival enlargement, gingival hyperplasia, gingival overgrowth, amlodipine, phenytoin, drug induced gingival enlargement